nach oben

Current Fungal Infection Reports

Erschienen in:

26.10.2017 | Clinical Mycology Lab Issues (S Córdoba, Section Editor)

A Comprehensive Analysis of MALDI-TOF MS and Ribosomal DNA Sequencing for Identification of Clinical Yeasts

verfasst von: Constanza Giselle Taverna, Mariana Mazza, Nicolas Refojo, Graciela Davel

Erschienen in: Current Fungal Infection Reports | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The purpose of this study is to analyze the current knowledge about matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) identification of clinical yeasts comparing with the ribosomal DNA sequencing identification. We also review the lasts taxonomical and nomenclature changes of clinical yeasts.

Recent Findings

In most studies, the two main commercially available, MALDI Biotyper and VITEK MS, correctly identified more than 90% of yeasts isolates. Most drawbacks are due to low discrimination between closely related species or due to a lack of the reference main spectra (MSP) in the database. The addition of MSPs in the databases improves the performance.

Summary

MALDI-TOF MS has proven to be good for the identification of clinical yeasts and to differentiate some closely related species or species undifferentiated by conventional techniques. However, some species remain difficult to differentiate by this technique and should be identified by ribosomal DNA sequencing. Accurate and rapid yeasts identification could improve the management of patients with yeasts infections.

Kurtzman CP, Fell JW, Boekhout T. The yeasts, a taxonomic study. London: Elsevier; 2011.

Alcoba-Flórez J, Méndez-Alvarez S, Cano J, Guarro J, Pérez-Roth E, del Pilar Arévalo M. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol. 2005;43(8):4107–11.CrossRefPubMedPubMedCentral

Correia A, Sampaio P, James S, Pais C. Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int J Syst Evol Microbiol. 2006;56(Pt 1):313–7.CrossRefPubMed

Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiol Read Engl. 1995;141(Pt 7):1507–21.CrossRef

Tavanti A, Davidson AD, Gow NAR, Maiden MCJ, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol. 2005;43(1):284–92.CrossRefPubMedPubMedCentral

Tietz HJ, Hopp M, Schmalreck A, Sterry W, Czaika V. Candida africana sp. nov., a new human pathogen or a variant of Candida albicans? Mycoses. 2001;44(11–12):437–45.CrossRefPubMed

Vaughan-Martini A, Kurtzman CP, Meyer SA, O’Neill EB. Two new species in the Pichia guilliermondii clade: Pichia caribbica sp. nov., the ascosporic state of Candida fermentati, and Candida carpophila comb. nov. FEMS Yeast Res. 2005;5(4–5):463–9.CrossRefPubMed

Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, Theelen B, Groenewald M, Kostrzewa M, et al. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol. 2012;50(11):3641–51.CrossRefPubMedPubMedCentral

Chaves GM, Terçarioli GR, Padovan ACB, Rosas RC, Ferreira RC, Melo ASA, et al. Candida mesorugosa sp. nov., a novel yeast species similar to Candida rugosa, isolated from a tertiary hospital in Brazil. Med Mycol. 2013;51(3):231–42.CrossRefPubMed

10.

Paredes K, Sutton DA, Cano J, Fothergill AW, Lawhon SD, Zhang S, et al. Molecular identification and antifungal susceptibility testing of clinical isolates of the Candida rugosa species complex and proposal of the new species Candida neorugosa. J Clin Microbiol. 2012;50(7):2397–403.CrossRefPubMedPubMedCentral

11.

Groenewald M, Daniel H-M, Robert V, Poot GA, Smith MT. Polyphasic re-examination of Debaryomyces hansenii strains and reinstatement of D. hansenii, D. fabryi and D. subglobosus. Persoonia. 2008;21:17–27.CrossRefPubMedPubMedCentral

12.

Castanheira M, Woosley LN, Diekema DJ, Jones RN, Pfaller MA. Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs. J Clin Microbiol. 2013;51(1):117–24.CrossRefPubMedPubMedCentral

13.

Desnos-Ollivier M, Ragon M, Robert V, Raoux D, Gantier J-C, Dromer F. Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii). J Clin Microbiol. 2008;46(10):3237–42.CrossRefPubMedPubMedCentral

14.

Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol. 2015;53(6):1823–30.CrossRefPubMedPubMedCentral

15.

Hawksworth DL, Crous PW, Redhead SA, Reynolds DR, Samson RA, Seifert KA, et al. The amsterdam declaration on fungal nomenclature. IMA Fungus. 2011;2(1):105–12.CrossRefPubMedPubMedCentral

16.

Taylor JW. One fungus = one name: DNA and fungal nomenclature twenty years after PCR. IMA Fungus. 2011;2(2):113–20.CrossRefPubMedPubMedCentral

17.

McNeill J, Barrie F, Buck W, Demoulin V, Greuter W, Hawksworth D, et al. International code of nomenclature for algae, fungi, and plants (Melbourne code). Australia: Koeltz Scientific Books; 2012.

18.

Tsui CKM, Daniel H-M, Robert V, Meyer W. Re-examining the phylogeny of clinically relevant Candida species and allied genera based on multigene analyses. FEMS Yeast Res. 2008;8(4):651–9.CrossRefPubMed

19.

Daniel H-M, Lachance M-A, Kurtzman CP. On the reclassification of species assigned to Candida and other anamorphic ascomycetous yeast genera based on phylogenetic circumscription. Antonie Van Leeuwenhoek. 2014;106(1):67–84.CrossRefPubMed

20.

Lachance MA. In defense of yeast sexual life cycles: the forma asexualis—an informal proposal. Yeast Newletter. 2012;61:24–5.

21.

Hagen F, Khayhan K, Theelen B, Kolecka A, Polacheck I, Sionov E, et al. Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex. Fungal Genet Biol FG B. 2015;78:16–48.CrossRefPubMed

22.

Liu X-Z, Wang Q-M, Göker M, Groenewald M, Kachalkin AV, Lumbsch HT, et al. Towards an integrated phylogenetic classification of the Tremellomycetes. Stud Mycol. 2015;81:85–147.CrossRefPubMed

23.

White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: PCR protocols: a guide to methods and applications. New York: Academic Press; 1990. p. 315–22.

24.

Pincus DH, Orenga S, Chatellier S. Yeast identification—past, present, and future methods. Med Mycol. 2007;45(2):97–121.CrossRefPubMed

25.

Iwen PC, Hinrichs SH, Rupp ME. Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med Mycol. 2002;40(1):87–109.CrossRefPubMed

26.

Schoch CL, Seifert KA, Huhndorf S, Robert V, Spouge JL, Levesque CA, et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi. Proc Natl Acad Sci U S A. 2012;109(16):6241–6.CrossRefPubMedPubMedCentral

27.

Irinyi L, Serena C, Garcia-Hermoso D, Arabatzis M, Desnos-Ollivier M, Vu D, et al. International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database—the quality controlled standard tool for routine identification of human and animal pathogenic fungi. Med Mycol. 2015;53(4):313–37.CrossRefPubMed

28.

Fungal XJ. DNA barcoding. Genome. 2016;59(11):913–32.CrossRef

29.

Taverna CG, Córdoba S, Murisengo OA, Vivot W, Davel G, Bosco-Borgeat ME. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina. Med Mycol. 2014;52(4):356–66.CrossRefPubMed

30.

Stielow JB, Lévesque CA, Seifert KA, Meyer W, Iriny L, Smits D, et al. One fungus, which genes? Development and assessment of universal primers for potential secondary fungal DNA barcodes. Persoonia. 2015;35:242–63.CrossRefPubMedPubMedCentral

31.

Vu D, Groenewald M, Szöke S, Cardinali G, Eberhardt U, Stielow B, et al. DNA barcoding analysis of more than 9 000 yeast isolates contributes to quantitative thresholds for yeast species and genera delimitation. Stud Mycol. 2016;85:91–105.CrossRefPubMedPubMedCentral

32.

Kurtzman CP, Robnett CJ. Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial sequences. Antonie Van Leeuwenhoek. 1998;73(4):331–71.CrossRefPubMed

33.

Fell JW, Boekhout T, Fonseca A, Scorzetti G, Statzell-Tallman A. Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis. Int J Syst Evol Microbiol. 2000;50(Pt 3):1351–71.CrossRefPubMed

34.

Taverna CG, Bosco-Borgeat ME, Murisengo OA, Davel G, Boité MC, Cupolillo E, et al. Comparative analyses of classical phenotypic method and ribosomal RNA gene sequencing for identification of medically relevant Candida species. Mem Inst Oswaldo Cruz. 2013;108(2):178–85.CrossRefPubMedPubMedCentral

35.

Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol. 2002;40(5):1826–30.CrossRefPubMedPubMedCentral

36.

Meyer W, Castañeda A, Jackson S, Huynh M, Castañeda E. IberoAmerican Cryptococcal Study Group. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis. 2003;9(2):189–95.CrossRefPubMedPubMedCentral

37.

Croxatto A, Prod’hom G, Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev. 2012;36(2):380–407.CrossRefPubMed

38.

Tan KE, Ellis BC, Lee R, Stamper PD, Zhang SX, Carroll KC. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J Clin Microbiol. 2012;50(10):3301–8.CrossRefPubMedPubMedCentral

39.

Posteraro B, Vella A, Cogliati M, De Carolis E, Florio AR, Posteraro P, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattii. J Clin Microbiol. 2012;50(7):2472–6.CrossRefPubMedPubMedCentral

40.

Bader O. Fungal species identification by MALDI-ToF mass spectrometry. Methods Mol Biol Clifton NJ. 2017;1508:323–37.CrossRef

41.

Santos C, Lima N, Sampaio P, Pais C. Matrix-assisted laser desorption/ionization time-of-flight intact cell mass spectrometry to detect emerging pathogenic Candida species. Diagn Microbiol Infect Dis. 2011;71(3):304–8.CrossRefPubMed

42.

Pfaller MA, Castanheira M. Nosocomial Candidiasis: antifungal stewardship and the importance of rapid diagnosis. Med Mycol. 2016;54(1):1–22.PubMed

43.

Santos CR, Francisco E, Mazza M, Padovan ACB, Colombo AL, Lima N. Impact of MALDI-TOF MS in clinical mycology; progress and barriers in diagnostics. In: Shah HR, Gharbia SE, editors. MALDI-TOF and tandem MS for clinical microbiology. Wiley: Chichester; 2017.

44.

Cassagne C, Normand A-C, L’Ollivier C, Ranque S, Piarroux R. Performance of MALDI-TOF MS platforms for fungal identification. Mycoses. 2016;59(11):678–90.CrossRefPubMed

45.

Wang H, Fan Y-Y, Kudinha T, Xu Z-P, Xiao M, Zhang L, et al. A comprehensive evaluation of the Bruker Biotyper MS and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of yeasts, part of the National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study, 2012 to 2013. J Clin Microbiol. 2016;54(5):1376–80.CrossRefPubMedPubMedCentral

46.

Stefaniuk E, Baraniak A, Fortuna M, Hryniewicz W. Usefulness of CHROMagar Candida medium, biochemical methods—API ID32C and VITEK 2 compact and two MALDI-TOF MS Systems for Candida spp. identification. Pol J Microbiol. 2016;65(1):111–4.CrossRefPubMed

47.

Kim T-H, Kweon OJ, Kim HR, Lee M-K. Identification of uncommon Candida species using commercial identification systems. J Microbiol Biotechnol. 2016;26(12):2206–13.CrossRefPubMed

48.

Lee HS, Shin JH, Choi MJ, Won EJ, Kee SJ, Kim SH, et al. Comparison of the Bruker Biotyper and VITEK MS matrix-assisted laser desorption/ionization time-of-flight mass spectrometry systems using a formic acid extraction method to identify common and uncommon yeast isolates. Ann Lab Med. 2017;37(3):223–30.CrossRefPubMedPubMedCentral

49.

Porte L, García P, Braun S, Ulloa MT, Lafourcade M, Montaña A, et al. Head-to-head comparison of microflex LT and Vitek MS systems for routine identification of microorganisms by MALDI-TOF mass spectrometry in Chile. PLoS One. 2017;12(5):e0177929.CrossRefPubMedPubMedCentral

50.

Mancini N, De Carolis E, Infurnari L, Vella A, Clementi N, Vaccaro L, et al. Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry systems for identification of yeasts of medical importance. J Clin Microbiol. 2013;51(7):2453–7.CrossRefPubMedPubMedCentral

51.

Chen JHK, Yam W-C, Ngan AHY, Fung AMY, Woo W-L, Yan M-K, et al. Advantages of using matrix-assisted laser desorption ionization-time of flight mass spectrometry as a rapid diagnostic tool for identification of yeasts and mycobacteria in the clinical microbiological laboratory. J Clin Microbiol. 2013;51(12):3981–7.CrossRefPubMedPubMedCentral

52.

Hamprecht A, Christ S, Oestreicher T, Plum G, Kempf VAJ, Göttig S. Performance of two MALDI-TOF MS systems for the identification of yeasts isolated from bloodstream infections and cerebrospinal fluids using a time-saving direct transfer protocol. Med Microbiol Immunol (Berl). 2014;203(2):93–9.CrossRef

53.

Jamal WY, Ahmad S, Khan ZU, Rotimi VO. Comparative evaluation of two matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) systems for the identification of clinically significant yeasts. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2014;26:167–70.

54.

Chao Q-T, Lee T-F, Teng S-H, Peng L-Y, Chen P-H, Teng L-J, et al. Comparison of the accuracy of two conventional phenotypic methods and two MALDI-TOF MS systems with that of DNA sequencing analysis for correctly identifying clinically encountered yeasts. PLoS One. 2014;9(10):e109376.CrossRefPubMedPubMedCentral

55.

Deak E, Charlton CL, Bobenchik AM, Miller SA, Pollett S, McHardy IH, et al. Comparison of the Vitek MS and Bruker microflex LT MALDI-TOF MS platforms for routine identification of commonly isolated bacteria and yeast in the clinical microbiology laboratory. Diagn Microbiol Infect Dis. 2015;81(1):27–33.CrossRefPubMed

56.

Pence MA, McElvania TeKippe E, Wallace MA, Burnham CA. Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2014;33(10):1703–12.CrossRef

57.

Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, Kuhns M. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2011;17(9):1359–65.

58.

Hou X, Xiao M, Chen SC, Wang H, Yu S-Y, Fan X, et al. Identification and antifungal susceptibility profiles of Candida nivariensis and Candida bracarensis in a multi-center Chinese collection of yeasts. Front Microbiol. 2017;8:5.PubMedPubMedCentral

59.

Haas M, Grenouillet F, Loubersac S, Ariza B, Pepin-Puget L, Alvarez-Moreno CA, et al. Identification of cryptic Candida species by MALDI-TOF mass spectrometry, not all MALDI-TOF systems are the same: focus on the C. parapsilosis species complex. Diagn Microbiol Infect Dis. 2016;86(4):385–6.CrossRefPubMed

60.

Gouriet F, Ghiab F, Couderc C, Bittar F, Tissot Dupont H, Flaudrops C, et al. Evaluation of a new extraction protocol for yeast identification by mass spectrometry. J Microbiol Methods. 2016;129:61–5.CrossRefPubMed

61.

Denis J, Machouart M, Morio F, Sabou M, Kauffmann-LaCroix C, Contet-Audonneau N, et al. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identifying clinical Malassezia isolates. J Clin Microbiol. 2017;55(1):90–6.CrossRefPubMed

62.

de Almeida JN, Sztajnbok J, da Silva AR, Vieira VA, Galastri AL, Bissoli L, et al. Rapid identification of moulds and arthroconidial yeasts from positive blood cultures by MALDI-TOF mass spectrometry. Med Mycol. 2016;54(8):885–9.CrossRef

63.

Vlek A, Kolecka A, Khayhan K, Theelen B, Groenewald M, Boel E, et al. Interlaboratory comparison of sample preparation methods, database expansions, and cutoff values for identification of yeasts by matrix-assisted laser desorption ionization-time of flight mass spectrometry using a yeast test panel. J Clin Microbiol. 2014;52(8):3023–9.CrossRefPubMedPubMedCentral

64.

Kolecka A, Khayhan K, Groenewald M, Theelen B, Arabatzis M, Velegraki A, et al. Identification of medically relevant species of arthroconidial yeasts by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2013;51(8):2491–500.CrossRefPubMedPubMedCentral

65.

De Carolis E, Vella A, Vaccaro L, Torelli R, Posteraro P, Ricciardi W, et al. Development and validation of an in-house database for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based yeast identification using a fast protein extraction procedure. J Clin Microbiol. 2014;52(5):1453–8.CrossRefPubMedPubMedCentral

66.

McTaggart LR, Lei E, Richardson SE, Hoang L, Fothergill A, Zhang SX. Rapid identification of Cryptococcus neoformans and Cryptococcus gattii by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2011;49(8):3050–3.CrossRefPubMedPubMedCentral

67.

Pinto A, Halliday C, Zahra M, van Hal S, Olma T, Maszewska K, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One. 2011;6(10):e25712.CrossRefPubMedPubMedCentral

Titel: A Comprehensive Analysis of MALDI-TOF MS and Ribosomal DNA Sequencing for Identification of Clinical Yeasts
verfasst von: Constanza Giselle Taverna
Mariana Mazza
Nicolas Refojo
Graciela Davel
Publikationsdatum: 26.10.2017
Verlag: Springer US
Erschienen in: Current Fungal Infection Reports / Ausgabe 4/2017
Print ISSN: 1936-3761
Elektronische ISSN: 1936-377X
DOI: https://doi.org/10.1007/s12281-017-0297-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Detection of Cryptic Candida Species Recognized as Human Pathogens Through Molecular Biology Techniques

The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach

Contribution of the National Mycology Laboratory Network to Surveillance of Cryptococcosis in Argentina

Erratum to: Harnessing Whole Genome Sequencing in Medical Mycology

Onychomycoses in a Military Population in Brazil